We are live on ! Find out more
CVSC

C.V. Starr & Co Portfolio holdings

AUM $192M
1-Year Est. Return 35.69%
This Fund
S&P 500
This Quarter Est. Return
-22.3%
1 Year Est. Return
+35.69%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$27.1M
AUM Growth
+$22.2M
Cap. Flow
+$27.6M
Cap. Flow %
101.84%
Top 10 Hldgs %
100%
Holding
2
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
CELU icon
Celularity
CELU
+$27.6M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 81.56%
2 Consumer Discretionary 18.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELU icon
1
Celularity
CELU
$21.7M
$22.1M 81.56%
+432,035
New +$27.6M
AMZN icon
2
Amazon
AMZN
$2.5T
$5M 18.44%
30,000

Similar funds

C.V. Starr & Co's Q4 2021 Portfolio in Review

As of Q4 2021, C.V. Starr & Co held 2 positions worth $27.1M, up 450% from $4.93M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

C.V. Starr & Co deployed $27.6M of net new capital in Q4 2021, opening 1 new position. Its largest new stake was Celularity: 432,035 shares worth $22.1M.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, followed by Consumer Discretionary.

  • C.V. Starr & Co's largest Q4 2021 buy was Celularity: 432,035 shares worth $22.1M.
  • C.V. Starr & Co's ten largest holdings make up 100% of its $27.1M portfolio in Q4 2021.
  • C.V. Starr & Co opened 1 new position and closed 0 in Q4 2021.
  • C.V. Starr & Co's portfolio value rose 450% quarter-over-quarter to $27.1M.

Based on C.V. Starr & Co's 13F filing for Q4 2021, filed 27 Jan 2022.